Elevated levels of soluble HLA class I (sHLA-I) in children with severe atopic dermatitis

Annals of Allergy, Asthma and Immunology

Volumn 79, Issue 2, 1997, Pages 113-118

  Moore, Cleveland ^a   Ehlayel, Mohammad ^a   Inostroza, Jaime ^b   Leiva, Lily E ^a   Sorensen, Ricardo U ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Hospital Regional de Temuco   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1;

ANTIGEN RECOGNITION; ARTICLE; ATOPIC DERMATITIS; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; HLA SYSTEM; HUMAN; INFANT; PRIORITY JOURNAL;

EID: 0030869619     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63096-7     Document Type: Article

References (50)

1. Ploegh HL, Orr HT, Strominger JL. Major histocompatibility antigens: the human (HLA-A, B, C) and murine (H-2K, H-2D) class I molecules. Cell 1981;24:287-99.
2. Daar AS, Fuggle SV, Fahre JW, et al. The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation 1984;38:287-92.
3. Alvarez-Cermeno JC, Casado C, Villar LM. Soluble class I antigens (sHLA) in CSF and serum of patients with HIV infection. Acta Neurol Scand 1990;82: 14-6.
4. 2-microglobulin in patients with active pulmonary tuberculosis. Hum Immunol 1994;40: 179-82.
5. McDonald JC, Gelder FB, Aultman DF. HLA in human serum quantitation of class I by enzyme immunoassay. Transplantation 1992;53:445-9.
6. Tilg H, Westhoff U, Vogel W, et al. Soluble HLA class I serum concentrations increase with transplant-related complications after liver transplantation. J Hepatol 1992;14:417-9.
7. Westhoff U, Leimenstoll G, Muller-Ruchholtz W. Soluble class I concentrations and GvHD after allogeneic marrow transplantation. Transplantation 1989;48:891-3.
8. Summary of serum-soluble HLA class I antigen component. HLA 1991. Oxford Science Publications, 1992: 1057-61.
9. Puppo F, Brenci S, Lanza L, et al. Increased level of serum HLA class I antigens in HIV infection: correlation with disease progression. Hum Immunol 1994;40:259-66.
10. Puppo F, Scudeletti M, Indiveri F, et al. Serum HLA class I antigens: markers and modulators of an immune response? Immunol Today 1995;16: 124-7.
11. Leung DY. The immunologic basis of atopic dermatitis. Clin Rev Allergy 1993;11:447-69.
12. Leung DY, Bhan AK, Schneeberger EE, et al. Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies. J Allergy Clin Immunol 1983;71: 47-56.
13. van Joost T, Kozel MM, Tank B, et al. Cyclosporine in atopic dermatitis: modulation in the expression of immunologic markers in lesional skin. J Am Acad Dermatol 1992;27:922-8.
14. Rossiter H, Van Riejsen F, Mudde CG. Skin disease-related T cells bind to endothelial selectins: expression of cutaneous lymphocyte antigen (CLA) predicts E-selectin but not P-selectin binding. Eur J Immunol 1994;24: 205-10.
15. Kagi M, Wuthrich B, Montano E, et al. Differential cytokine profiles in peripheral blood lymphocyte supernatants and skin biopsies from patients with different forms of atopic dermatitis, psoriasis and normal individuals. Int Arch Allergy Immunol 1994;103: 322-40.
16. Walker C, Kagi MK, Ingold P, et al. Atopic dermatitis: correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity. Clin Exp Allergy 1993;23: 145-52.
17. Santamaria Babi LF, Picker LJ, Perez Soler MT, et al. Circulating allergen-reactive T cells from patients with the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen. J Exp Med 1995;181:1935-40.
18. Rubin LA, Kurman CC, Fritz ME. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985;135: 3172-7.
19. Clover GB, Symons JA, Duff GW. Soluble interleukin-2 receptor in atopic eczema. Br Med J 1989;298: 1426-8.
20. Wuthrich B, Joller-Jemelka H, Helfenstein U, et al. Levels of soluble interleukin-2 receptors correlate with the severity of atopic dermatitis. Dermatologica 1990;181:92-7.
21. Symons JA, Wood NC, Di Giovine FS, et al. Soluble interleukin 2 receptor in rheumatic diseases: correlation with disease activity, interleukin 1 and interleukin 2 inhibition. J Immunol 1988;141:2612-8.
22. Wolf RE, Brelsford WG. Soluble interleukin-2 receptors in systemic lupus erythematosus. Arthritis Rheum 1988; 31:729-35.
23. He X, Le J. An alternative splicing of HLA class I transcripts induced by interferon-gamma and tumor necrosis factor in fibroblasts: release of soluble HLA class I heavy chain and an associated protein. Cell Immunol 1995; 162:159-68.
24. Le J, Hua J-C. Production of soluble HLA-class-I molecules by IFN-gamma induced colon-adenocarcinoma cells. Int J Cancer 1995;60: 576-81.
25. Aulitzky WE, Grosse-Wilde H, Westhoff U, et al. Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-gamma). Clin Exp Immunol 1991;86: 236-9.
26. Reinhold U, Wehrmann W, Kukel S, et al. Evidence that defective interferon-gamma production in atopic dermatitis patients is due to intrinsic abnormalities. Clin Exp Immunol 1990;79: 374-9.
27. Jujo K, Genz H, Abe J, et al. Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis. J Allergy Clin Immunol 1992;90: 323-31.
28. Hamid Q, Boguniewicz M, Leung DYM. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994;94:870-6.
29. Tang M, Kemp A. Production and secretion of interferon-gamma in children with atopic dermatitis. Clin Exp Immunol 1994;95:66-72.
30. Kapp A. Atopic dermatitis-the skin manifestation of atopy. Clin Exp Allergy 1995;25:210-9.
31. Thepen T, Langeveld-Wildschut EG, Bihari IC, et al. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial Th2 response to a Th1 response in situ: an immunocytochemical study. J Allergy Clin Immunol 1996;97:828-37.
32. Grewe M, Gyufko K, Schopf E, et al. Lesional expression of interferon-gamma in atopic eczema. Lancet 1994; 343:25-6.
33. Hamid Q, Naseer T, Minshall EM, et al. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol 1996;98:225-31.
34. Hsieh CS, Macatonia SE, Tripp CS, et al. Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993; 260:547-9.
35. Manetti R, Parronchi P, Guidizi MG, et al. Natural killer cell stimulatory factor (interleukin-12) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4 producing Th cells. J Exp Med 1993;177:1199-204.
36. Chan SH, Perussia B, Gupta JW, et al. Induction of interferon-gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 1991;173: 869-79.
37. Leyden JE, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974;90:525-30.
38. Andersson J, Nagy S, Bjork S, et al. Bacterial toxin-induced cytokine production studied at the single-cell level. Immunol Rev 1992;127:69-95.
39. Neuber K, Steinrucke K, Ring J. Staphylococcal enterotoxin B affects in vitro IgE synthesis, interferon-gamma, interleukin-4 and interleukin-5 production in atopic eczema. Int Arch Allergy Immunol 1995;107: 179-82.
40. Galli SJ, Gordon JR, Wershil BK. Mast cell cytokines in allergy and inflammation. Agents Actions Suppl 1993;43:209-20.
41. Steffen M, Abboud M, Potter GK, et al. Presence of tumour necrosis factor or a related factor in human basophil/ mast cells. Immunology 1989;66: 445-50.
42. Benyon RC, Bissonette EY, Befus AD. Tumor necrosis factor-alpha dependent cytotoxicity of human skin mast cells is enhanced by anti-IgE antibodies. J Immunol 1991;147:2253-8.
43. Walsh LJ, Trinchieri G, Waldorf HA, et al. Human dermal mast cells contain and release tumour necrosis factor alpha which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 1991;88:4220-4.
44. Puppo F, Pellicci R, Brenci S, et al. HLA class-I-soluble antigen serum levels in liver transplantation: a predictor marker of acute rejection. Hum Immunol 1994;40:166-70.
45. Sampson HA, Broadbent KR, Bernhisel-Broadbent J. Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity. N Engl J Med 1989;321: 228-32.
46. Doxiadis I, Westhoff U, Grose-Wilde H. Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay. Blut 1989;59: 449-54.
47. Schultz LFS, Holm NV, Henningsen K. Atopic dermatitis. A genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1986;15:487-94.
48. Schultz Larsen F. Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1993;28:719-23.
49. Blumenthal MN, Mendell N, Yunis E. Immunogenetics of atopic diseases. J Allergy Clin Immunol 1980;65:403-5.
50. Svejgaard E, Jakobsen B, Svejgaard A. Studies of HLA-ABC and DR antigens in pure atopic dermatitis and atopic dermatitis combined with allergic respiratory disease. Acta Derm Venereol [Suppl] (Stockh) 1985;114: 72-6.